Cargando…
PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1
BACKGROUND: Drug resistance remains a great challenge in the treatment of pancreatic cancer. The goal of this study was to determine whether TGF-β1 is associated with drug resistance in pancreatic cancer. METHODS: Pancreatic cancer BxPC3 cells were stably transfected with TGF-β1 cDNA. Cellular morph...
Autores principales: | Chen, Ying, Yu, Guanzhen, Yu, Danghui, Zhu, Minghua |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924847/ https://www.ncbi.nlm.nih.gov/pubmed/20684793 http://dx.doi.org/10.1186/1756-9966-29-104 |
Ejemplares similares
-
PKC is an indispensable factor in promoting environmental toxin chromium-mediated transformation and drug resistance
por: Ganapathy, Suthakar, et al.
Publicado: (2022) -
PKCδ regulates integrin α(V)β(3) expression and transformed growth of K-ras dependent lung cancer cells
por: Symonds, Jennifer M., et al.
Publicado: (2016) -
PKCα and PKCδ: Friends and Rivals
por: Black, Jennifer D., et al.
Publicado: (2022) -
Src, PKCα, and PKCδ are required for αvβ3 integrin-mediated metastatic melanoma invasion
por: Putnam, Andrew J, et al.
Publicado: (2009) -
ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth
por: Li, Yongmei, et al.
Publicado: (2011)